Nurix Therapeutics, Inc. (NRIX)

Nurix Therapeutics Stock Forecast

Stock Price Forecast

According to 15 professional analysts, the 12-month price target for Nurix Therapeutics stock ranges from a low of $16 to a high of $41. The average analyst price target of $29.13 forecasts a 175.59% increase in the stock price over the next year.

Price Target: $29.13 (+175.59%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$16	$29.13	$30	$41
Change	+51.37%	+175.59%	+183.82%	+287.89%

Analyst Ratings

The average analyst rating for Nurix Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Feb '25	Mar '25	Apr '25	May '25	Jun '25	Jul '25
Strong Buy	7	7	7	7	7	6
Buy	9	8	8	8	8	7
Hold	1	2	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	17	17	17	17	17	15

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Matthew Biegler Oppenheimer	Oppenheimer	Buy Reiterates $32 → $30	Buy	Reiterates	$32 → $30	+183.82%	Jul 31, 2025
Terence Flynn Morgan Stanley	Morgan Stanley	Hold Maintains $17 → $16	Hold	Maintains	$17 → $16	+51.37%	Jul 15, 2025
Robert Burns HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $36 → $34	Strong Buy	Maintains	$36 → $34	+221.67%	Jul 14, 2025
David Dai UBS	UBS	Strong Buy Maintains $30 → $26	Strong Buy	Maintains	$30 → $26	+145.98%	Jul 10, 2025
Matthew Biegler Oppenheimer	Oppenheimer	Buy Maintains $32 → $30	Buy	Maintains	$32 → $30	+183.82%	Jul 10, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

93.56M

Increased by 71.51%

from 54.55M

Revenue Next Year

62.72M

Decreased by -32.97%

from 93.56M

EPS This Year

-3.00

from -2.88

EPS Next Year

-3.49

from -3.00

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Nov 30, 2020	Nov 30, 2021	Nov 30, 2022	Nov 30, 2023	Nov 30, 2024	Nov 30, 2025	Nov 30, 2026	Nov 30, 2027
Revenue	17.82M	29.75M	38.63M	76.99M	54.55M	93.56M	62.72M	83.58M
Revenue Growth	-42.73%	66.95%	29.84%	99.31%	-29.15%	71.51%	-32.97%	33.27%
EPS	-2.76	-2.73	-3.71	-2.65	-2.88	-3.00	-3.49	-3.31
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	20	20	15

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	118.6M	99.8M	224.5M
Avg	93.6M	62.7M	83.6M
Low	61.3M	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	117.4%	6.6%	258.0%
Avg	71.5%	-33.0%	33.3%
Low	12.3%	-	-

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-2.14	-2.07	-1.63
Avg	-3.00	-3.49	-3.31
Low	-3.19	-4.51	-4.17

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.